The evolution of biotechnology in bioregions and their globalisation

International Journal of Biotechnology

Volumn 10, Issue 5, 2008, Pages 476-495

  Cooke, Philip ^a  

^a UNIVERSITY OF WALES   (United Kingdom)

Author keywords

Clusters; Industry organisation; Market interactions; Open science; Regional development

Indexed keywords

COMMERCE; REGIONAL PLANNING;

CLUSTERS; INDUSTRY ORGANISATION; MARKET INTERACTIONS; OPEN SCIENCE; REGIONAL DEVELOPMENT;

BIOTECHNOLOGY;

BIOTECHNOLOGY; CLUSTER ANALYSIS; GLOBAL ECONOMY; GLOBALIZATION; INNOVATION; MARKET CONDITIONS; REGIONAL DEVELOPMENT;

BIOMEDICINE; BIOTECHNOLOGICAL PROCEDURES; COMMERCIAL PHENOMENA; DRUG INDUSTRY; ECONOMIC ASPECT; ECONOMIC DEVELOPMENT; EVOLUTIONARY DEVELOPMENTAL BIOLOGY; FOOD BIOTECHNOLOGY; HEALTH CARE UTILIZATION; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; REVIEW;

EID: 56549097455     PISSN: 09636048     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJBT.2008.021311     Document Type: Review

References (51)

1. Bagchi-Sen, S. and Scully, J. (2004) 'The Canadian environment for innovation and business development in the biotechnology industry; a firm-level analysis', European Planning Studies, Vol. 12, pp.961-984.
2. Bazdarich, M. and Hurd, J. (2003) Anderson Forecast: Inland Empire and Bay Area, Los Angeles, Anderson Business School.
3. Carlsson, B. (Ed) (2001) New Technological Systems in the BioIndustries: An International Study, London: Kluwer.
4. Casper, S. and Karamanos, A. (2003) 'Commercialising science in Europe: the Cambridge biotechnology cluster', European Planning Studies, Vol. 11, pp.805-822.
5. Chesbrough, H. (2003) Open Innovation, Boston: Harvard Business School Press.
6. Coenen, L., Moodysson, J. and Asheim, B. (2004) 'Nodes, networks and proximities: on the knowledge dynamics of the Medicon Valley biotech cluster', European Planning Studies, Vol. 12, pp.1003-1018.
7. Cooke, P. (2002) 'Rational drug design and the rise of bioscience megacentres', Presented at the Fourth Triple Helix Conference, Breaking Boundaries - Building Bridges', Copenhagen and Lund, 6-9 November.
8. Cooke, P. (2003) 'The evolution of biotechnology in three continents: Schumpeterian or Penrosian?' European Planning Studies, Vol. 11, pp.757-764.
9. Cooke, P. (2004) 'Globalisation of bioregions: the rise of knowledge capability, receptivity and diversity', Regional Industrial Research Report 44, Cardiff, Centre for Advanced Studies.
10. Cooke, P. (2005) 'Rational drug design, the knowledge value chain and bioscience megacentres', Cambridge Journal of Economics, Vol. 29, pp.325-342.
11. Cortright, J. and Mayer, H. (2002) Signs of Life: the Growth of Biotechnology Centres in the US, Washington, DC, The Brookings Institute.
12. De la Mothe, J. and Niosi, J. (Eds) (2000) The Economics and Spatial Dynamics of Biotechnology, London: Kluwer.
13. Dorey, E. (2003) 'Emerging market Medicon Valley: a hotspot for biotech affairs', BioResource, March, Available at: www.investintech.com.
14. DTI (1999) Biotechnology Clusters, London, Department of Trade and Industry.
15. Feldman, M. and Francis, J. (2003) 'Fortune favours the prepared region: the case of entrepreneurship and the Capitol Region biotechnology cluster', European Planning Studies, Vol. 11, pp.757-764.
16. Finegold, D., Wong, P. and Cheah, T. (2004) 'Adapting a foreign direct investment strategy to the knowledge economy: the case of Singapore's emerging biotechnology cluster', European Planning Studies, Vol. 12, pp.921-942.
17. Freeman, C. (1987) Technology Policy and Economic Performance: Lessons from Japan, London: Pinter.
18. Fuchs, G. (Ed) (2003) Biotechnology in Comparative Perspective, London: Routledge.
19. Gregersen, B. (1992) 'The public sector as a pacer in National Systems of Innovation', in Lundvall, B. (Ed). National Systems of Innovation, London: Pinter.
20. Hall, P. and Markusen, A. (Eds). (1985) Silicon Landscapes, London: Allen & Unwin.
21. Henderson, R., Orsenigo, L. and Pisano, G. (1999) 'The pharmaceutical industry and the revolution in molecular biology: interactions among scientific, institutional and organisational change', in D. Mowery and R. Nelson (Eds). Sources of Industrial Leadership, Cambridge: Cambridge University Press.
22. Johnson, J. (2002) ''Valley' in the Alps', Financial Times, 27 February, p.10.
23. Kaiser, R. (2003) 'Multi-level science policy and regional innovation: the case of the Munich cluster for pharmaceutical biotechnology', European Planning Studies, Vol. 11, pp.841-858.
24. Kaufmann, D., Schwartz, D., Frenkel, A. and Shefer, D. (2003) 'The role of location and regional networks for biotechnology firms in Israel', European Planning Studies, Vol. 11, pp.823-840.
25. Kettler, H. and Casper, S. (2000) The Road to Sustainability in the UK and German Biotechnology Industries, London, Office of Health Economics.
26. Lawton Smith, H. (2004) 'The biotechnology industry in Oxfordshire: enterprise and innovation', European Planning Studies, Vol. 12, pp.985-1002.
27. Lawton Smith, H. and Bagchi-Sen, S. (2004) 'Guest editorial: innovation geographies; international perspectives on research, product development, and commercialisation of biotechnologies', Environment and Planning C: Government and Policy, Vol. 22, pp.159-160.
28. Lee, C. and Walshok, M. (2001) Making Connections, Report to University of California, Office of the President.
29. Lundvall, B. (Ed) (1992) National Systems of Innovation, London: Pinter.
30. Maillat, D. (1998) 'Interactions between urban systems and localised productive systems: an approach to endogenous regional development in terms of innovative milieu', European Planning Studies, Vol. 6, pp.117-130.
31. March, J. (1991) 'Exploration and exploitation in organisational learning', Organization Science, Vol. 2, pp.71-87.
32. McKelvey, M. (1996) Evolutionary Innovation: The Business of Biotechnology, Oxford: Oxford University Press.
33. Nelson, R. (Ed) (1993) National Innovation Systems, Oxford: Oxford University Press.
34. Niosi, J. and Bas, T. (2003) 'Biotechnology megacentres: Montreal and Toronto regional systems of innovation', European Planning Studies, Vol. 11, pp.789-804.
35. OECD (2000) Health Data, Paris, Organisation for Economic Co-operation and Development.
36. Orsenigo, L. (1989) The Emergence of Biotechnology, New York: St. Martin's Press.
37. Orsenigo, L., Pammolli, F. and Riccaboni, M. (2001) 'Technological change and network dynamics: lessons from the pharmaceutical industry', Research Policy, Vol. 30, pp.485-508.
38. Owen-Smith, J. and Powell, W. (2004) 'Knowledge networks as channels and conduits: the effects spillovers in the Boston biotechnology community', Organization Science, Vol. 15, pp.5-21.
39. Parkes, C. (2004) 'Job losses in Silicon Valley worse than first feared', Financial Times, 25 March, p.9.
40. Penrose, E. (1959) The Theory of the Growth of the Firm, Oxford: Oxford University Press.
41. Powell, W., Koput, K., Bowie, J. and Smith-Doerr, L. (2002) 'The spatial clustering of science and capital: accounting for biotech firm-venture capital relationships', Regional Studies, Vol. 36, pp.291-305.
42. Raagmaa, G. and Tamm, P. (2004) 'An emerging biomedical business in a low capitalised country', European Planning Studies, Vol. 12, pp.943-960.
43. Rallet, A. and Torre, A. (1998) 'On geography and technology: proximity relations on localised innovation networks', in M. Steiner (Ed). Clusters and Regional Specialisation, London: Pion.
44. Ryan, C. and Phillips, P. (2004) 'Knowledge management in advanced technology industries: an examination of international agricultural biotechnology clusters', Environment and Planning C: Government and Policy, Vol. 22, pp.217-232.
45. Sassen, S. (1994) Cities in a World Economy, Thousand Oaks: Pine Forge Press.
46. Schumpeter, J. (1975) Capitalism, Socialism and Democracy, New York: Harper & Row.
47. Small Business Economics (2001) Special Issue: Biotechnology in Comparative Perspective - Regional Concentration and Industry Dynamics (Guest Editors: Gerhard Fuchs & Gerhard Krauss), Vol. 17, pp.1-153.
48. Wickelgren, I. (2002) The Gene Masters, New York: Times Books.
49. Wolter, K. (2002) Can the US Experience be Repeated? The Evolution of Biotechnology in Three European Regions, (mimeo), Duisburg University, Germany.
50. Zeller, C. (2002) 'Regional and North Atlantic knowledge production in the pharmaceutical industry', in V. Lo and E. Schamp (Eds). Knowledge - The Spatial Dimension, Münster: Lit-Verlag.
51. Zucker, L., Darby, M. and Armstrong, J. (1998) 'Geographically localised knowledge: spillovers or markets?' Economic Inquiry, Vol. 36, pp.65-86.